CDC advisory group says benefits of Johnson & Johnson vaccine outweigh risks

cdc advisory group says benefits of johnson johnson vaccine outweigh risks

Sumary of CDC advisory group says benefits of Johnson & Johnson vaccine outweigh risks:

  • Johnson COVID-19 vaccine, despite its potential link to Guillain-Barré syndrome.
  • Johnson vaccine is “very low,” usually occurring within 6 weeks.
  • Johnson vaccine, as well as its benefits, including the vaccine’s role in controlling the spread of the Delta variant.
  • Johnson vaccine accounts for 4% of total COVID-19 vaccine doses administered in the U.S., Sarah Mbaeyi, MD, MPH, a medical officer at the CDC, said during the meeting.
  • Johnson vaccine, according to Meghna Alimchandani, MD, a medical officer at the FDA.
  • Lee, MD, MPH, chair of the ACIP COVID-19 Vaccine Safety Technical Subgroup, said that the crude number of GBS cases in the Vaccine Adverse Event Reporting System is about 8.1 per million doses with the Johnson &
  • In contrast, the crude number of GBS cases is 1.1 per million doses with the mRNA vaccines.
  • The expected number of GBS cases is about 1.6 per million doses, Lee said.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close